89 Infos zu Andreas Marzinzik

5 Aktuelle Nachrichten

Dr. Andreas Marzinzik. Novartis S.A., Basel, CH. Toward the goal of curing CML: Discovery of ABL001,. a novel allosteric inhibitor of BCR-ABL.

Medicinal chemist Dr. Andreas Marzinzik, who is a Director and a Leading Scientist at Novartis Global Discovery in Basel, is giving a special ...

Dr. Carsten Hopf (HS Mannheim), Prof. Dr. Anna Kathrin Hirsch (HIPS Saarbrücken), Prof. Dr. Maja Köhn (Uni Freiburg), Prof. Dr. Andreas Marx (Uni Konstanz), Dr. Andreas Marzinzik (Novartis, Basel), Dr. Pierre Stallforth (HKI Jena ) und Prof. Dr. Roderich Süßmuth (TU Berlin). Autor: Maren Mielck. zurück.

7 Profile in Sozialen Netzwerken

Sehen Sie sich das berufliche Profil von Andreas Marzinzik (Schweiz) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und

berufliche Netzwerk, das Fach- und Führungskräften wie Andreas Marzinzik ...

上领英，在全球领先职业社交平台查看Andreas Marzinzik的职业档案。Andreas的职业档案列出了3 个职位。查看Andreas的完整档案，结识职场人脉和查看相似公司 ...

2 Hobbys & Interessen

Aug. 16, PRLog -- Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes ...

diseases.... Inventors: Frederic Berst, Pascal Furet, Andreas Marzinzik (Novartis Ag)

1 Business-Profile

NOVARTIS AG, Weil, DE

1 Firmen-Mitarbeiter

Board of the BCG. Prof. Olivier Baudoin (University of Basel). Dr. Carsten Kroll (Roche). Dr. Olivier Loiseleur (Syngenta). Dr. Andreas Marzinzik (Novartis). Prof.

2 Bücher zum Namen

This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on...

Kurz vor der Jahrtausendwende hat die Synthesechemie nochmals einen signifikanten Innovationsschub erfahren: Die effiziente Herstellung einer Vielfalt von...

3 Dokumente

Dr. Andreas Marzinzik Novartis. Discovery of ABL001: A New Allosteric Inhibitor of BCR-ABL. Dr. Ingo Münster BASF SE. Material Innovations ...

... University of Zaragoza (Spain), .es B. Solid Phase Chemistry and Combinatorial Synthesis Convener: Dr. Andreas Marzinzik, Novartis ...

Authors: Florian Nigsch, Werner Breitenstein, Edgar Jacoby, Maxim Popov, Philipp Krastel, Jeremy Jenkins, Ian Lewis, Andreas Marzinzik, ...

1 Wissenschaftliche Publikationen

wissen.leben - Die WWU Münster - eine renommierte Hochschule in einer sympathischen Stadt.

2 Allgemeine Veröffentlichungen

Simona Cotesta. series ordinal references. Andreas Marzinzik. series ordinal references. Xavier Pellé. series ordinal references. Martin Geiser.

Abstract: The synthesis of combinatorial compound libraries has become a powerful lead finding tool in modern drug discovery.

6 Meinungen & Artikel

Although FPPS is a potential anti-cancer target, the high bone affinity of nitrogen-containing bisphosphonates, FPPS inhibitors used clinically to treat bone...

... Markus Warmuth, Xavier Pelle, Robert Grotzfeld, Frederic Berst, Andreas Marzinzik, Sandra W. Cowan-Jacob, Pascal Furet, Jürgen Mestan.

... Combinatorial Synthesis Convener: Dr. Andreas Marzinzik, Novartis Pharma AG (Switzerland), andreas.marzinzik()at()pharma.novartis.com ...

The 5th International Electronic Conference on Synthetic Organic Chemistry

53 Webfunde aus dem Netz

Requerente, Peter Josef Flor, Andreas Marzinzik, Novartis Ag, Novartis Pharma Gmbh, Joachim Nozulak, Silvio Ofner, Bernard Roy, Carsten Spanka. Exportar ...

The present invention relates to the crystal structure of the serine protease kallikrein 7 and to the use of this crystal structure in drug discovery....

... Shimpei Kawakami: Kazuhide Konishi: Juergen Klaus Maibaum: Andreas Marzinzik: Keiichi Masuya: Nils Ostermann: Fumiaki Yokokawa: Juerg Zimmermann ...

Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, ...

Andreas Marzinzik currently working as an Director at Novartis.He completed his Dr.rer.nat.(PhD) Organic Chemistry at University of Essen,in

Press Release issued Aug 17, 2011: Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for...

Inventors, Werner Breitenstein, Claus Ehrhardt, Juergen Klaus Maibaum, Nils Ostermann, Juerg Zimmermann, Keiichi Masuya, Kazuhide Konishi, Fumiaki Yokokawa, Takanori Kanazawa, Edgar Jacoby, Andreas Marzinzik, Philipp Grosche, Shimpei Kawakami. Applicant, Novartis Ag, Werner Breitenstein, ...

Dr. Andreas Marzinzik . Novartis . U K : Prof. Mark Bradley. Soton University: Mike Davis, Argonaut Technologies *: not yet elected. Referee: Kim Andersen . 1.

central resource for events in human genetics and molecular biology

posted on , 17:00 by Antonella Converso Kristina Burow Andreas Marzinzik K. Barry Sharpless M. G. Finn. The title compound, the condensation ...

15 International PhD Positions in Drug Discovery FRAGNET. 15 International PhD Positions In Drug Discovery : Amsterdam, York, Budapest,

Andreas Marzinzik,. Andreas Marzinzik *. 1Novartis Institutes for Biomedical Research, Inc, Cambridge, MA. Search for other works by this ...

posted on , 17:00 by Nils Ostermann Simon Ruedisser Claus Ehrhardt Werner Breitenstein Andreas Marzinzik Edgar Jacoby Eric Vangrevelinghe ...

Dr. andreas marzinzik. Ale ale kannada song download. Offentlig rom sprakradet. Photoshop gradient map portrait. Ale ale kannada song download.

Download "KGF-SCS Industrial Science Awards" ... Dr. Ian Lewis from Novartis Pharma AG, ... of SOM230 by both EMEA and FDA in Dr. Andreas Marzinzik (Novartis, ...

... for the Display of Nucleophilic Components. Antonella Converso, Kristina Burow, Andreas Marzinzik, K. Barry Sharpless, M. G. Finn ... Andreas Marzinzik ...

... Simona Cotesta, Andreas Marzinzik, Xavier Pelle, Martin Geiser, André Strauss, Marjo Götte, Francis Bitsch, René Hemmig, Chrystèle Henry, Sylvie Lehmann, ...

Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a ...

Dr. Andreas Marzinzik, Chairman of Solid Phase Chemistry and Combinatorial Synthesis Symposium (SPCCSS2001) Program Head - ICLF Novartis Pharma ...

Nils Ostermann, Simon Ruedisser, Claus Ehrhardt, Werner Breitenstein, Andreas Marzinzik, Edgar Jacoby, Eric Vangrevelinghe, Johannes Ottl, Martin Klumpp, ...